Skip to main content Back to Top
Advertisement

10/25/2019

Thrombin Topical Powder (Recombinant)

Products Affected - Description

    • Recothrom topical powder, Baxter, 20,000 unit kit, with spray pump spray bottle, syringe spray tip, syringe, bowl 1 count, NDC 43825-0707-50

Reason for the Shortage

    • Baxter did not provide a reason for the shortage.

Available Products

    • Recothrom topical powder, Baxter, 20,000 unit vial, with 20 mL prefilled diluent syringe plus 20 mL empty syringe 1 count, NDC 43825-0707-41
    • Recothrom topical powder, Baxter, 5,000 unit vial, with 5 mL prefilled diluent syringe plus 5 mL empty syringe 1 count, NDC 43825-0606-41

Estimated Resupply Dates

    • Baxter has Recothrom 20,000 unit pump spray kits on back order and the company estimates a release date of early-December 2019.

Updated

Updated October 25, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 7, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins